Clinical characteristics of patients with remitting seronegative symmetrical synovitis with pitting edema compared to patients with pure polymyalgia rheumatica

Journal of Rheumatology

Volumn 39, Issue 1, 2012, Pages 148-153

  Kimura, Makiko ^a,c   Tokuda, Yasuharu ^b,c   Oshiawa, Hideto ^a,c   Yoshida, Kazuki ^a,c   Utsunomiya, Masako ^a,c   Kobayashi, Tatsuo ^a,c   Deshpande, Gautam A ^c   Matsui, Kazuo ^a,c   Kishimoto, Mitsumasa ^c  

^a KAMEDA MEDICAL CENTER   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

Author keywords

Paraneoplastic syndrome; Polymyalgia rheumatica; Remitting seronegative symmetrical synovitis with pitting edema

Indexed keywords

CORTICOSTEROID;

ADULT; AGE DISTRIBUTION; AGED; ANOREXIA; ARTICLE; CANCER SCREENING; CLINICAL FEATURE; COMMUNITY HOSPITAL; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; ERYTHROCYTE SEDIMENTATION RATE; FATIGUE; FEMALE; FOLLOW UP; HIP PAIN; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; POLYARTHRITIS; PRIORITY JOURNAL; REMITTING SERONEGATIVE SYMMETRICAL SYNOVITIS WITH PITTING EDEMA; RETROSPECTIVE STUDY; RHEUMATIC POLYMYALGIA; SEX DIFFERENCE; SMOKING; SYSTEMIC DISEASE; TREATMENT RESPONSE;

ADRENAL CORTEX HORMONES; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; EDEMA; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; POLYMYALGIA RHEUMATICA; RETROSPECTIVE STUDIES; SYNOVITIS;

EID: 84855399144     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110558     Document Type: Article

References (39)

1. McCarty DJ, O'Duffy JD, Pearson L, Hunter JB. Remitting seronegative symmetrical synovitis with pitting edema: RS3PE syndrome. JAMA 1985;254:2763-7. (Pubitemid 16243296)
2. Russell EB, Hunter JB, Pearson L, McCarty DJ. Remitting, seronegative, symmetrical synovitis with pitting edema - 13 additional cases. J Rheumatol 1990;17:633-9. (Pubitemid 20201740)
3. Chaouat D, Le Parc JM. The syndrome of seronegative symmetrical synovitis with pitting edema (RS3PE syndrome): A unique form of arthritis in the elderly? Report of 4 additional cases. J Rheumatol 1989;16:1211-3. (Pubitemid 19260109)
4. Sattar MA. Remitting seronegative symmetrical synovitis with pitting oedema in young adults: A subset of rheumatoid arthritis or a distinct syndrome? Br J Rheumatol 1990;29:479-81.
5. Healey LA. RS3PE syndrome. J Rheumatol 1990;17:414.
6. Olivieri I, Padula A, Favaro L, Oranges GS, Ferri S. RS3PE syndrome with unilateral involvement. J Rheumatol 1994;21:372.
7. Olivieri I, Salvarani C, Cantini F. Remitting distal extremity swelling with pitting edema: a distinct syndrome or a clinical feature of different inflammatory rheumatic diseases? J Rheumatol 1997;24:249-52.
8. Schaeverbeke T, Fatout E, Marce S, Vernhes JP, Hallé O, Antoine JF, et al. Remitting seronegative symmetrical synovitis with pitting edema: Disease or syndrome? Ann Rheum Dis 1995;54:681-4.
9. Yao Q, Su X, Altman RD. Is remitting seronegative symmetrical synovitis with pitting edema (RS3PE) a subset of rheumatoid arthritis? Semin Arthritis Rheum 2010;40:89-94.
10. Dejaco C, Wipfler E, Duftner C, Kriessmayr M, Rogatsch H, Breitenhuber D, et al. Remitting seronegative syndrome with pitting edema as the presenting symptom in a young, male patient with sarcoidosis: A case report. Arthritis Rheum 2008;59:148-52. (Pubitemid 351171891)
11. Magy N, Michel F, Auge B, Toussirot E, Wendling D. Amyloid arthropathy revealed by RS3PE syndrome. Joint Bone Spine 2000;67:475-7.
12. Dasgupta B, Cimmino MA, Maradit-Kremers H, Schmidt WA, Schirmer M, Salvarani C, et al. Development of classification criteria for polymyalgia rheumatic (PMR): Results from an international, prospective, multi-center longitudinal study. ACR-EULAR Study Group for Development of Classification Criteria for PMR [abstract]. Arthritis Rheum 2010;62 Suppl:S689.
13. Keenan RT, Hamalian GM, Pillinger MH. RS3PE presenting in a unilateral pattern: Case report and review of the literature. Semin Arthritis Rheum 2009;38:428-33.
14. Billey T, Navaux F, Lassoued S. Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) as the first manifestation of periarteritis nodosa. Report of a case. Rev Rhum Engl Ed 1995;62:53-4.
15. Manganelli P, Delsante G, Bianchi G, Fietta P, Quaini F. Remitting seronegative symmetrical synovitis with pitting oedema in a patient with myelodysplastic syndrome and relapsing polychondritis. Clin Rheumatol 2001;20:132-5. (Pubitemid 32401291)
16. Kato T, Ubara Y, Sawa N, Tagami T, Katori H, Takemoto F, et al. An abrupt onset of seropositive polyarthritis with prominent distal tenosynovitis concomitant with bronochiolitis obliterans organizing pneumonia (BOOP): Consideration of the relationship with RS3PE syndrome. Intern Med 2004;43:143-7. (Pubitemid 38325168)
17. Roldan MR, Martinez F, Roman J, Torres A. Non-Hodgkin's lymphoma: initial manifestation. Ann Rheum Dis 1993;52:85-6.
18. Sibilia J, Friess S, Schaeverbeke T, Maloisel F, Bertin P, Goichot B, et al. Remitting seronegative symmetrical synovitis with pitting edema (RS3PE): A form of paraneoplastic polyarthritis? J Rheumatol 1999;26:115-20. (Pubitemid 29051406)
19. Cantini F, Salvarani C, Olivieri I. Paraneoplastic remitting seronegative symmetrical synovitis with pitting edema. Clin Exp Rheumatol 1999;17:741-4.
20. Nakashima H, Tanaka Y, Shigematsu H, Kanaya S, Otsuka T, Hayashida K, et al. Remitting seronegative symmetrical synovitis with pitting edema syndrome associated with cryptogenic hepatocellular carcinoma [letter]. Clin Exp Rheumatol 1999;17:390-1. (Pubitemid 29265695)
21. Vinci M, Malaguarnera L, Pistone G. RS3PE and ovarian cancer [letter]. Ann Rheum Dis 2001;60:429-31.
22. Sayarlioglu M. Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome and malignancy. Eur J Gen Med 2004;1:3-5.
23. Salvarini C, Gabriel SE, O'Fallon WM, Hunder GG. Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970-1991. Arthritis Rheum 1995;38:369-73.
24. Olive A, del Blanco J, Pons M, Vaquero M, Tena X, Catalan Group for the Study of RS3PE. The clinical spectrum of remitting seronegative symmetrical synovitis with pitting edema. J Rheumatol 1997;24:333-6. (Pubitemid 27104099)
25. Paira S, Graf C, Roverano S, Rossini J. Remitting seronegative symmetrical synovitis with pitting oedema: A study of 12 cases. Clin Rheumatol 2002;21:146-9. (Pubitemid 34649597)
26. Bucaloiu ID, Olenginski TP, Harrington TM. Remitting seronegative symmetrical synovitis with pitting edema syndrome in a rural tertiary care practice: A retrospective analysis. Mayo Clin Proc 2007;82:1510-5. (Pubitemid 350211699)
27. Salvarani C, Macchioni PL, Tartoni PL, Rossi F, Baricchi R, Castri C, et al. Polymyalgia rheumatica and giant cell arteritis: A 5-year epidemiological and clinical study in Reggio Emilia, Italy. Clin Exp Rheumatol 1987;5:205-15. (Pubitemid 18037233)
28. Cantini F, Salvarani C, Olivieri I, Barozzi L, Macchioni L, Niccoli L, et al. Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) syndrome: A prospective follow up and magnetic resonance imaging study. Ann Rheum Dis 1999;58:230-6. (Pubitemid 29191654)
29. Schaeverbeke T, Vernhes JP, Bannwarth B, Dehais J. Is remitting seronegative symmetrical synovitis with pitting oedema (RS3PE syndrome) associated with HLA-A2? [letter]. Br J Rheumatol 1995;34:889-90.
30. Salvarani C, Cantini F, Macchioni P, Olivieri I, Niccoli L, Padula A, et al. Distal musculoskeletal manifestations in polymyalgia rheumatica: A prospective followup study. Arthritis Rheum 1998;41:1221-6. (Pubitemid 28313424)
31. Gran JT, Myklebust G. The incidence and clinical characteristics of peripheral arthritis in polymyalgia rheumatica and temporal arteritis: A prospective study of 231 cases. Rheumatology 2000;39:283-7. (Pubitemid 30204212)
32. Pease CT, Haugeberg G, Montague B, Hensor EMA, Bhakta BB, Thomson W, et al. Polymyalgia rheumatica can be distinguished from late onset rheumatoid arthritis at baseline: Results of a 5-yr prospective study. Rheumatology 2009;48:123-7.
33. Kremers HM, Reinalda MS, Crowson CS, Zinsmeister AR, Hunder GG, Gabriel SE. Relapse in a population based cohort of patients with polymyalgia rheumatica. J Rheumatol 2005;32:65-73. (Pubitemid 40092593)
34. Salvarani C, Gabriel S, Hunder G. Distal extremity swelling with pitting edema in polymyalgia rheumatica. Report of nineteen cases. Arthritis Rheum 1996;39:73-80.
35. von Knorring J, Somer T. Malignancy in association with polymyalgia rheumatica and temporal arteritis. Scand J Rheumatol 1974;3:129-35.
36. Bengtsson BA, Malmvall BE. Prognosis of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Acta Med Scand 1981;209:337-45.
37. Boesen P, Sorensen SF. Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a Danish county. A prospective investigation, 1982-1985. Arthritis Rheum 1987;30:294-9. (Pubitemid 17098581)
38. Haga HJ, Eide GE, Brun J, Johansen A, Langmark F. Cancer in association with polymyalgia rheumatica and temporal arteritis. J Rheumatol 1993;20:1335-9. (Pubitemid 23310985)
39. Dasgupta B, Salvarani C, Schirmer M, Crowson CS, Maradit-Kremers H, Hutchings A, et al. Developing classification criteria for polymyalgia rheumatica: Comparison of views from an expert panel and wider survey. J Rheumatol 2008;35:270-7. (Pubitemid 351281148)